Literature DB >> 22789945

Defining the diagnosis in echocardiographically suspected senile systemic amyloidosis.

Candida Cristina Quarta, Pier Luigi Guidalotti, Simone Longhi, Cinzia Pettinato, Ornella Leone, Alessandra Ferlini, Elena Biagini, Francesco Grigioni, Maria Letizia Bacchi-Reggiani, Massimiliano Lorenzini, Agnese Milandri, Angelo Branzi, Claudio Rapezzi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22789945     DOI： 10.1016/j.jcmg.2012.02.015

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN： 1876-7591


× No keyword cloud information.
  9 in total

1.  Pattern of myocardial 99mTc-HMDP uptake and impact on myocardial function in patients with transthyretin cardiac amyloidosis.

Authors:  Sarah Pradel; Stéphanie Brun; Gérard Victor; Pierre Pascal; Pauline Fournier; David Ribes; Yoan Lavie-Badie; Michel Galinier; Didier Carrié; Isabelle Berry; Olivier Lairez
Journal:  J Nucl Cardiol       Date:  2018-06-07       Impact factor: 5.952

2.  ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging.

Authors:  Sharmila Dorbala; Yukio Ando; Sabahat Bokhari; Angela Dispenzieri; Rodney H Falk; Victor A Ferrari; Marianna Fontana; Olivier Gheysens; Julian D Gillmore; Andor W J M Glaudemans; Mazen A Hanna; Bouke P C Hazenberg; Arnt V Kristen; Raymond Y Kwong; Mathew S Maurer; Giampaolo Merlini; Edward J Miller; James C Moon; Venkatesh L Murthy; C Cristina Quarta; Claudio Rapezzi; Frederick L Ruberg; Sanjiv J Shah; Riemer H J A Slart; Hein J Verberne; Jamieson M Bourque
Journal:  J Nucl Cardiol       Date:  2019-12       Impact factor: 5.952

Review 3.  Cardiac amyloidosis: the great pretender.

Authors:  Claudio Rapezzi; Massimiliano Lorenzini; Simone Longhi; Agnese Milandri; Christian Gagliardi; Ilaria Bartolomei; Fabrizio Salvi; Mathew S Maurer
Journal:  Heart Fail Rev       Date:  2015-03       Impact factor: 4.214

Review 4.  Nuclear imaging modalities for cardiac amyloidosis.

Authors:  Sabahat Bokhari; Reehan Shahzad; Adam Castaño; Mathew S Maurer
Journal:  J Nucl Cardiol       Date:  2014-02       Impact factor: 5.952

5.  Analogies and disparities among scintigraphic bone tracers in the diagnosis of cardiac and non-cardiac ATTR amyloidosis.

Authors:  Claudio Rapezzi; Christian Gagliardi; Agnese Milandri
Journal:  J Nucl Cardiol       Date:  2018-02-22       Impact factor: 5.952

Review 6.  Cardiac Amyloid - An Update.

Authors:  Jason N Dungu
Journal:  Eur Cardiol       Date:  2015-12

Review 7.  Cardiovascular magnetic resonance for amyloidosis.

Authors:  Marianna Fontana; Robin Chung; Philip N Hawkins; James C Moon
Journal:  Heart Fail Rev       Date:  2015-03       Impact factor: 4.214

8.  Evaluation of Therapeutic Oligonucleotides for Familial Amyloid Polyneuropathy in Patient-Derived Hepatocyte-Like Cells.

Authors:  Christoph J Niemietz; Vanessa Sauer; Jacqueline Stella; Lutz Fleischhauer; Gursimran Chandhok; Sarah Guttmann; Yesim Avsar; Shuling Guo; Elizabeth J Ackermann; Jared Gollob; Brett P Monia; Andree Zibert; Hartmut H-J Schmidt
Journal:  PLoS One       Date:  2016-09-01       Impact factor: 3.240

Review 9.  Guideline of transthyretin-related hereditary amyloidosis for clinicians.

Authors:  Yukio Ando; Teresa Coelho; John L Berk; Márcia Waddington Cruz; Bo-Göran Ericzon; Shu-ichi Ikeda; W David Lewis; Laura Obici; Violaine Planté-Bordeneuve; Claudio Rapezzi; Gerard Said; Fabrizio Salvi
Journal:  Orphanet J Rare Dis       Date:  2013-02-20       Impact factor: 4.123
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.